|
Volumn , Issue , 2015, Pages 123-128
|
Targeting the PI3K Pathway in Head and Neck Squamous Cell Carcinoma
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE B;
PROTEIN KINASE INHIBITOR;
TARGET OF RAPAMYCIN KINASE;
ANIMAL;
CARCINOMA, SQUAMOUS CELL;
DRUG DEVELOPMENT;
DRUG EFFECTS;
HEAD AND NECK NEOPLASMS;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOMARKERS;
CARCINOMA, SQUAMOUS CELL;
DRUG DISCOVERY;
HEAD AND NECK NEOPLASMS;
HUMANS;
MOLECULAR TARGETED THERAPY;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-AKT;
SIGNAL TRANSDUCTION;
TOR SERINE-THREONINE KINASES;
TREATMENT OUTCOME;
|
EID: 85003052214
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2015.35.123 Document Type: Review |
Times cited : (41)
|
References (0)
|